Anika Therapeutics | Resultado Líquido





Resultado Líquido Alterar Data
Abbott USD 1.78B 132M 2025-12
Agenus USD -25.27M 20.59M 2025-03
Agios Pharmaceuticals USD -103.43M 8.59M 2025-09
Anika Therapeutics USD -4.87M 16.99M 2025-03
Arrowhead Research USD 30.81M 54.56M 2025-12
Enanta Pharmaceuticals USD -22.29M 93.76M 2024-12
Halozyme Therapeutics USD 175.22M 10.06M 2025-09
Heron Therapeutics USD -4.85M 4.39M 2024-09
Insmed USD -370.02M 48.34M 2025-09
Integra LifeSciences USD -5.4M 478.67M 2025-09
J&J USD 5.12B 36M 2025-12
Karyopharm Therapeutics USD -30.78M 1.29M 2024-12
Ligand Pharmaceuticals USD 117.27M 112.43M 2025-09
MacroGenics USD 16.82M 53.07M 2025-09
Merit Medical Systems USD 27.76M 4.83M 2025-09
Rigel Pharmaceuticals USD 12.42M 13.45M 2024-09
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Sanofi EUR -801M 3.6B 2025-12
Smith & Nephew USD 293M 79M 2025-12
Stryker USD 849M 10M 2025-12
Surmodics USD -11.54M 3.99M 2024-09
Veracyte USD 19.14M 20.12M 2025-09
Xencor USD -6.03M 24.8M 2025-09
Zimmer Biomet Holdings USD 139.3M 91.6M 2025-12


Anika Therapeutics Resultado Líquido - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.